[Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways].
D000498:Allyl Compounds / Q000494:pharmacology*; D015153:Blotting, Western; D018797:Cell Cycle Proteins / Q000502:physiology; D002455:Cell Division / Q000187:drug effects; D045744:Cell Line, Tumor; D004220:Disulfides / Q000494:pharmacology*; D004789:Enzyme Activation; D005434:Flow Cytometry; D016195:G2 Phase / Q000187:drug effects*; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology*; D008938:Mitosis / Q000187:drug effects*; D013274:Stomach Neoplasms / Q000201:enzymology / Q000473:pathology*; D020687:cdc25 Phosphatases / Q000502:physiology; D048051:p38 Mitogen-Activated Protein Kinases
D000498:Allyl Compounds; D018797:Cell Cycle Proteins; D004220:Disulfides; C028009:diallyl disulfide; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; C517009:CDC25C protein, human; D020687:cdc25 Phosphatases